NO20010833L - Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler - Google Patents

Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Info

Publication number
NO20010833L
NO20010833L NO20010833A NO20010833A NO20010833L NO 20010833 L NO20010833 L NO 20010833L NO 20010833 A NO20010833 A NO 20010833A NO 20010833 A NO20010833 A NO 20010833A NO 20010833 L NO20010833 L NO 20010833L
Authority
NO
Norway
Prior art keywords
composition
component
mucoadhesive compositions
active ingredients
compositions containing
Prior art date
Application number
NO20010833A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010833D0 (no
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vienneau
Christopher Robert Mayer
Kishorkumar Jivanlal Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20010833L publication Critical patent/NO20010833L/no
Publication of NO20010833D0 publication Critical patent/NO20010833D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010833A 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler NO20010833D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24
PCT/US1999/019140 WO2000010527A1 (fr) 1998-08-24 1999-08-24 Compositions mucoadhesives renfermant des -ubstances actives au niveau gastro-intestinal

Publications (2)

Publication Number Publication Date
NO20010833L true NO20010833L (no) 2001-02-19
NO20010833D0 NO20010833D0 (no) 2001-02-19

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010833A NO20010833D0 (no) 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Country Status (15)

Country Link
US (1) US20010016577A1 (fr)
EP (1) EP1115378A1 (fr)
JP (1) JP2002523352A (fr)
KR (1) KR20010072463A (fr)
CN (1) CN1313755A (fr)
AU (1) AU5685299A (fr)
BR (1) BR9913227A (fr)
CA (1) CA2338688A1 (fr)
CO (1) CO5140071A1 (fr)
HU (1) HUP0103216A2 (fr)
ID (1) ID27728A (fr)
NO (1) NO20010833D0 (fr)
PE (1) PE20000860A1 (fr)
TR (1) TR200100629T2 (fr)
WO (1) WO2000010527A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
KR100990810B1 (ko) * 2001-12-21 2010-10-29 알콘, 인코퍼레이티드 안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도
AU2003268672A1 (en) * 2002-09-26 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Drug absorbability improving agents
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
SI3354276T1 (sl) 2007-11-13 2020-09-30 Meritage Pharma, Inc. Sestavki za zdravljenje gastrointestinalnega vnetja
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
BR112012008087A2 (pt) * 2009-08-05 2016-03-01 Tyco Healthcare curativo de ferimento cirúrgico incorporando esferas de hidrogel conectadas tendo um eletrodo embutido naquele lugar
EP2386289A1 (fr) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Compositions d'argile
JP2014501258A (ja) * 2010-12-23 2014-01-20 コルゲート・パーモリブ・カンパニー 構造化剤を含む流体組成物
CN103974691A (zh) 2011-12-15 2014-08-06 高露洁-棕榄公司 水性口腔护理组合物
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
AU2012396256B2 (en) 2012-12-03 2015-11-19 Colgate-Palmolive Company Manufacturing processes for gellan gum-based fluid gels
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9486460B2 (en) * 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN106255495B (zh) 2014-04-29 2019-10-22 宝洁公司 用于制备含铋的液体药物悬浮液的方法
EP3632478B1 (fr) 2014-07-14 2022-09-28 University of Utah Research Foundation Solution solidification in situ et ses procédés de fabrication et d'utilisation
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
US11896234B2 (en) 2018-01-26 2024-02-13 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (fr) * 1993-03-12 1994-09-15 The Procter & Gamble Company Compositions a base d'adsorbats

Also Published As

Publication number Publication date
AU5685299A (en) 2000-03-14
JP2002523352A (ja) 2002-07-30
CO5140071A1 (es) 2002-03-22
ID27728A (id) 2001-04-26
CA2338688A1 (fr) 2000-03-02
US20010016577A1 (en) 2001-08-23
TR200100629T2 (tr) 2001-07-23
BR9913227A (pt) 2001-05-22
HUP0103216A2 (hu) 2002-01-28
EP1115378A1 (fr) 2001-07-18
CN1313755A (zh) 2001-09-19
WO2000010527A1 (fr) 2000-03-02
PE20000860A1 (es) 2000-09-11
NO20010833D0 (no) 2001-02-19
KR20010072463A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
NO20010833L (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
MX9702865A (es) Agentes estrogenicos.
NO982414L (no) Ny kombinasjon
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
NO20052335L (no) Dispergerbare deferacirox-tabletter
NO952863D0 (no) Fluoxetin-farmasöytiske sammensetninger
NO20010486L (no) Betennelseshemmende tannpleiemidler
CA2378428A1 (fr) Utilisation d'antagonistes de cgrp et d'inhibiteurs de secretion cgrp servant a lutter contre les bouffees de chaleur de la menopause
PT814789E (pt) Composicoes farmaceuticas compreendendo inibidores de monoamina-oxidase b
AR024240A1 (es) COMPUESTOS DE 4-(AMINOMETIL)-PIPERIDIN BENZAMIDA uTILES PARA TRATAR TRASTORNOS GASTROINTESTINALES, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE, PROCESO PARA PREPARAR DICHA COMPOSICIoN FARMACÉUTICA, COMPUESTO INTERMEDIARIO uTIL PARA PREPARA DICHOS COMPUESTOS DE BENZAMIDA, PROCESO PARA PREPARAR DICHOS
WO2001001972A3 (fr) ANTAGONISTES SELECTIFS DU RECEPTEUR iGluR5 UTILISES DANS LE TRAITEMENT DE LA MIGRAINE
NO20005981D0 (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2003045326A3 (fr) Procede de preparation et d'utilisation d'huile de ricin polyoxyethylee dans des compositions pharmaceutiques
NO975726L (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
HUP0100390A2 (hu) Eljárás baktericid hatás kifejtésére baktericid zsírsavszappan-frakciót tartalmazó készítmény alkalmazásával
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NO20022971L (no) Butyndiol-derivater
CA2348693A1 (fr) Formulation naturelle pour le traitement et la prevention de la depression et contenant st. john's wort et des derives de l'acide dihydro- et tetrahydrofolique
US20120094882A1 (en) Denture Cleanser
ATE473962T1 (de) C2-disubstituierte indan-1-one und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20073728L (no) Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application